DE60326839D1 - Verfahren zur verbesserung einer bindungseigenschaft eines moleküls - Google Patents

Verfahren zur verbesserung einer bindungseigenschaft eines moleküls

Info

Publication number
DE60326839D1
DE60326839D1 DE60326839T DE60326839T DE60326839D1 DE 60326839 D1 DE60326839 D1 DE 60326839D1 DE 60326839 T DE60326839 T DE 60326839T DE 60326839 T DE60326839 T DE 60326839T DE 60326839 D1 DE60326839 D1 DE 60326839D1
Authority
DE
Germany
Prior art keywords
molecule
improving
bonding property
present
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326839T
Other languages
English (en)
Inventor
Volker Schellenberger
Christopher J Murray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor International Inc filed Critical Genencor International Inc
Application granted granted Critical
Publication of DE60326839D1 publication Critical patent/DE60326839D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1086Preparation or screening of expression libraries, e.g. reporter assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
DE60326839T 2002-06-12 2003-06-09 Verfahren zur verbesserung einer bindungseigenschaft eines moleküls Expired - Lifetime DE60326839D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38838602P 2002-06-12 2002-06-12
PCT/US2003/018187 WO2003107009A2 (en) 2002-06-12 2003-06-09 Methods for improving a binding characteristic of a molecule

Publications (1)

Publication Number Publication Date
DE60326839D1 true DE60326839D1 (de) 2009-05-07

Family

ID=29736463

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326839T Expired - Lifetime DE60326839D1 (de) 2002-06-12 2003-06-09 Verfahren zur verbesserung einer bindungseigenschaft eines moleküls

Country Status (8)

Country Link
US (2) US20060088838A1 (de)
EP (2) EP2107116A3 (de)
AT (1) ATE426815T1 (de)
AU (1) AU2003248652A1 (de)
CA (1) CA2489022C (de)
DE (1) DE60326839D1 (de)
DK (1) DK1512015T3 (de)
WO (1) WO2003107009A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1942203A (zh) * 2004-06-04 2007-04-04 金克克国际有限公司 使用抗体重链的筛选方法
WO2006116076A2 (en) 2005-04-28 2006-11-02 Genencor International, Inc. Tab molecules
EP4238993A3 (de) 2008-04-11 2023-11-29 Chugai Seiyaku Kabushiki Kaisha Antigenbindendes molekül zur wiederholten bindung an zwei oder mehr antigenmoleküle
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
SG190727A1 (en) 2010-11-30 2013-07-31 Chugai Pharmaceutical Co Ltd Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
KR102147548B1 (ko) 2011-02-25 2020-08-24 추가이 세이야쿠 가부시키가이샤 FcγRIIb 특이적 Fc 항체
TW201817745A (zh) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之FcRn結合域的治療性抗原結合分子
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
EP3517550A1 (de) 2011-11-30 2019-07-31 Chugai Seiyaku Kabushiki Kaisha Arzneimittelhaltiger träger in zellen zur bildung eines immunkomplexes
LT2825036T (lt) 2012-03-16 2018-07-10 Regeneron Pharmaceuticals, Inc. Histidino pakeitimus lengvoje grandinėje turintys antikūnai ir genetiškai modifikuoti graužikai, išvesti ju gamybai
RS59076B1 (sr) 2012-03-16 2019-09-30 Regeneron Pharma Glodari koji eksprimiraju imunoglobulinske sekvence senzitivne na ph
TWI808330B (zh) 2014-12-19 2023-07-11 日商中外製藥股份有限公司 抗肌抑素之抗體、含變異Fc區域之多胜肽及使用方法
SG11201607165YA (en) 2014-12-19 2016-09-29 Chugai Pharmaceutical Co Ltd Anti-c5 antibodies and methods of use
TW202248212A (zh) 2015-02-05 2022-12-16 日商中外製藥股份有限公司 包含離子濃度依賴之抗原結合域的抗體、Fc區變體、IL-8結合抗體與其用途
TW202339800A (zh) 2015-02-27 2023-10-16 日商中外製藥股份有限公司 Il-6受體抗體用於製備醫藥組成物的用途
EP3394098A4 (de) 2015-12-25 2019-11-13 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin-antikörper und verfahren zur verwendung
EP3494991A4 (de) 2016-08-05 2020-07-29 Chugai Seiyaku Kabushiki Kaisha Zusammensetzung zur vorbeugung oder behandlung von erkrankungen im zusammenhang mit il-8
JP7191833B2 (ja) 2017-01-30 2022-12-19 中外製薬株式会社 抗スクレロスチン抗体およびその使用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2207301A (en) 1937-05-15 1940-07-09 Nat Electric Prod Corp Underfloor duct
US2209701A (en) 1938-03-08 1940-07-30 Andrew J Mcgann Device for cutting or scoring necks of bottles
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US5200313A (en) * 1983-08-05 1993-04-06 Miles Inc. Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
US4711845A (en) 1984-08-31 1987-12-08 Cetus Corporation Portable temperature-sensitive control cassette
US4666848A (en) 1984-08-31 1987-05-19 Cetus Corporation Polypeptide expression using a portable temperature sensitive control cassette with a positive retroregulatory element
EP0196864A3 (de) 1985-03-25 1988-03-23 Cetus Corporation Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
EP2369007B1 (de) * 1996-05-29 2015-07-29 Cornell Research Foundation, Inc. Erkennung von Nukleinsäuresequenz-Unterschieden mittels der gleichzeitigen Ligaseerkennungs- und Polymerasekettenreaktion
JP3935509B2 (ja) * 1997-02-12 2007-06-27 ワイ. チャン,ユージーン ポリマー分析のための方法および製品
AU2002351193A1 (en) * 2001-11-28 2003-06-10 Mj Bioworks Incorporated Parallel polymorphism scoring by amplification and error correction
WO2004031408A1 (en) * 2002-09-30 2004-04-15 F.Hoffmann-La Roche Ag Oligonucleotides for genotyping thymidylate synthase gene
US7354706B2 (en) * 2003-09-09 2008-04-08 The Regents Of The University Of Colorado, A Body Corporate Use of photopolymerization for amplification and detection of a molecular recognition event
WO2005047521A2 (en) * 2003-11-10 2005-05-26 Investigen, Inc. Methods of preparing nucleic acid for detection

Also Published As

Publication number Publication date
EP1512015B1 (de) 2009-03-25
WO2003107009A3 (en) 2004-04-15
US20060088838A1 (en) 2006-04-27
US20080146456A1 (en) 2008-06-19
DK1512015T3 (da) 2009-07-06
CA2489022A1 (en) 2003-12-24
EP2107116A3 (de) 2009-12-09
AU2003248652A1 (en) 2003-12-31
CA2489022C (en) 2012-10-16
EP2107116A2 (de) 2009-10-07
WO2003107009A2 (en) 2003-12-24
EP1512015A2 (de) 2005-03-09
ATE426815T1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
DE60326839D1 (de) Verfahren zur verbesserung einer bindungseigenschaft eines moleküls
EP2581450A3 (de) Mit nichtnatürlichen Aminosäuren substituierte Polypeptide
WO2009026393A3 (en) Amino acid substituted molecules
ATE475419T1 (de) Verfahren zur zubereitung von lansoprazol
ATE474847T1 (de) Verfahren zur herstellung von dipeptiden
EP2395091A3 (de) Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu deren Herstellung
DE60336867D1 (de) Verfahren zur Herstellung von 3-Halo-4,5-Dihydro-1H-Pyrazolen
ATE535529T1 (de) Verfahren zur acylierung von maytansinol mit chiralen aminosäuren
ATE451380T1 (de) Verfahren zur herstellung von bisphosphonsäureverbindungen
WO2007113237A3 (en) Plants having enhanced yield-related traits and a method for making the same
ATE486844T1 (de) Verfahren zur herstellung von adipodinitril durch hydrocyanierung von 1,3-butadien
ATE555202T1 (de) Verfahren zur lieferung von rna-interferenz und verwendungen damit
WO2004106380A3 (en) Human-anti-human cd3 binding molecules
DE60219968D1 (de) Verfahren zur Produktion von L-Aminosäuren mittels Bakterien der Gattung Escherichia
WO2008015263A3 (en) Plants having improved characteristics and a method for making the same
DE602007009954D1 (de) Verfahren zur identifizierung von polypeptid-targets
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
DE602004026500D1 (de) Verfahren zur Markierung phosphorylierten Peptiden, Komplexverbindunger, Verfahren zu deren Herstellung und Zwischenprodukte
ATE506370T1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
ATE407130T1 (de) Verfahren zur herstellung von 2- azetidinonderivaten
DE602006015458D1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
ATE451457T1 (de) Verfahren zur dipeptidherstellung
ATE553194T1 (de) Verfahren zur dipeptidherstellung
ATE403480T1 (de) Verfahren und ausrüstungen zur reinigung von proteinen mit his-tag
DE602004016006D1 (de) Screening-verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition